David Faxon

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. doi request reprint How to manage antiplatelet therapy for stenting in a patient requiring oral anticoagulants
    David P Faxon
    Brigham and Women s Hospital, 1620 Tremont St, Boston, MA, 02120, USA
    Curr Treat Options Cardiovasc Med 15:11-20. 2013
  2. doi request reprint Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study
    David P Faxon
    Cardiovascular Division, Veterans Affairs Boston Healthcare System, Boston, MA, USA
    Circ Cardiovasc Interv 5:372-80. 2012
  3. doi request reprint Facts and controversies of aspirin and clopidogrel therapy
    David P Faxon
    Department of Medicine, Brigham and Women s Hospital, Boston, MA 02120, USA
    Am Heart J 157:412-22. 2009
  4. ncbi request reprint New data on early management of patients with ST-elevation myocardial infarction
    David P Faxon
    Division of Cardiology, Department of Medicine, Brigham and Women s Hospital, 1620 Tremont Street, OBC 3 12N, Boston, MA 02120, USA
    Curr Cardiol Rep 10:291-8. 2008
  5. doi request reprint Optimizing antiplatelet therapy in acute coronary syndrome and percutaneous coronary intervention
    David P Faxon
    Division of Cardiology, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02120, USA
    Catheter Cardiovasc Interv 79:181-97. 2012
  6. doi request reprint Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective
    David P Faxon
    Division of Cardiology, Brigham and Women s Hospital, 1620 Tremont Street, OBC 3 12J, Boston, MA 02120, USA
    Thromb Haemost 106:572-84. 2011
  7. ncbi request reprint Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary
    David P Faxon
    Brigham and Women s Hospital, 1620 Tremont St, Boston, MA 02120, USA
    Circ Cardiovasc Interv 4:522-34. 2011
  8. doi request reprint Antiplatelet therapy for postdischarge medical management of acute coronary syndrome
    David Faxon
    Department of Medicine, Brigham and Women s Hospital, Boston, MA 02120, USA
    Am J Med 121:171-8. 2008
  9. ncbi request reprint Usefulness of noncoronary vascular disease in predicting adverse events in the year following percutaneous coronary intervention
    Srihari S Naidu
    Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Am J Cardiol 95:575-80. 2005
  10. ncbi request reprint From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II
    Morteza Naghavi
    The Center for Vulnerable Plaque Research, University of Texas Houston, The Texas Heart Institute, and President Bush Center for Cardiovascular Health, Memorial Hermann Hospital, Houston, USA
    Circulation 108:1772-8. 2003

Detail Information

Publications55

  1. doi request reprint How to manage antiplatelet therapy for stenting in a patient requiring oral anticoagulants
    David P Faxon
    Brigham and Women s Hospital, 1620 Tremont St, Boston, MA, 02120, USA
    Curr Treat Options Cardiovasc Med 15:11-20. 2013
    ..Presently, however, limiting the duration of triple therapy followed by clopidogrel and an oral anticoagulant seems the best option for the majority of patients to minimize bleeding risk without an increase in other adverse events...
  2. doi request reprint Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study
    David P Faxon
    Cardiovascular Division, Veterans Affairs Boston Healthcare System, Boston, MA, USA
    Circ Cardiovasc Interv 5:372-80. 2012
    ..Current guidelines recommend combining clopidogrel with aspirin for up to 1 year after coronary stenting, but the value of clopidogrel beyond this time is uncertain...
  3. doi request reprint Facts and controversies of aspirin and clopidogrel therapy
    David P Faxon
    Department of Medicine, Brigham and Women s Hospital, Boston, MA 02120, USA
    Am Heart J 157:412-22. 2009
    ..Overall, despite the existing controversies, antiplatelet therapy with aspirin and/or clopidogrel remains a proven and essential therapeutic tool for safe and effective management of atherothrombotic risk in specific clinical settings...
  4. ncbi request reprint New data on early management of patients with ST-elevation myocardial infarction
    David P Faxon
    Division of Cardiology, Department of Medicine, Brigham and Women s Hospital, 1620 Tremont Street, OBC 3 12N, Boston, MA 02120, USA
    Curr Cardiol Rep 10:291-8. 2008
    ..National efforts to reduce delays and to improve access to timely therapy will significantly reduce mortality even further...
  5. doi request reprint Optimizing antiplatelet therapy in acute coronary syndrome and percutaneous coronary intervention
    David P Faxon
    Division of Cardiology, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02120, USA
    Catheter Cardiovasc Interv 79:181-97. 2012
    ..Most importantly, early and effective antiplatelet therapy results in the best short- and long-term outcomes for patients with ACS or those undergoing PCI...
  6. doi request reprint Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective
    David P Faxon
    Division of Cardiology, Brigham and Women s Hospital, 1620 Tremont Street, OBC 3 12J, Boston, MA 02120, USA
    Thromb Haemost 106:572-84. 2011
    ....
  7. ncbi request reprint Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary
    David P Faxon
    Brigham and Women s Hospital, 1620 Tremont St, Boston, MA 02120, USA
    Circ Cardiovasc Interv 4:522-34. 2011
    ....
  8. doi request reprint Antiplatelet therapy for postdischarge medical management of acute coronary syndrome
    David Faxon
    Department of Medicine, Brigham and Women s Hospital, Boston, MA 02120, USA
    Am J Med 121:171-8. 2008
    ..Primary care physicians are well placed to influence adherence through their ongoing relationships with patients and can save lives by implementing secondary risk reduction measures after discharge...
  9. ncbi request reprint Usefulness of noncoronary vascular disease in predicting adverse events in the year following percutaneous coronary intervention
    Srihari S Naidu
    Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Am J Cardiol 95:575-80. 2005
    ..Because PCI is often performed before vascular surgery, these data may lend insight to the risk/benefit ratio of such an approach...
  10. ncbi request reprint From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II
    Morteza Naghavi
    The Center for Vulnerable Plaque Research, University of Texas Houston, The Texas Heart Institute, and President Bush Center for Cardiovascular Health, Memorial Hermann Hospital, Houston, USA
    Circulation 108:1772-8. 2003
    ..We encourage healthcare policy makers to promote translational research for screening and treatment of vulnerable patients...
  11. ncbi request reprint Strategies to improve early reperfusion in ST-elevation myocardial infarction
    David P Faxon
    Bringham and Women s Hospital and Boston Medical Center, Boston, Massachusetts, USA
    Rev Cardiovasc Med 8:127-34. 2007
    ..Although these strategies may help, there is growing enthusiasm for the development of primary PCI centers, with triage of patients to these centers through either an EMS bypass system or an interhospital transfer system...
  12. ncbi request reprint ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999
    Elliott M Antman
    Circulation 110:588-636. 2004
  13. ncbi request reprint Early reperfusion strategies after acute ST-segment elevation myocardial infarction: the importance of timing
    David P Faxon
    Section of Cardiology, University of Chicago, IL 60637, USA
    Nat Clin Pract Cardiovasc Med 2:22-8. 2005
    ....
  14. ncbi request reprint Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention
    Alice K Jacobs
    Circulation 113:2152-63. 2006
    ..Working within a framework of guiding principles, the group will recommend strategies to increase the number of STEMI patients with timely access to primary PCI...
  15. doi request reprint Prevention of intravenous contrast-induced nephropathy in hospital inpatients
    Rahul Kakkar
    Department of Medicine, Brigham and Women s Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA
    Crit Pathw Cardiol 7:1-4. 2008
    ..On the basis of the recently published clinical trial data and guidelines from the major radiologic societies, we developed an algorithmic approach to CIN prophylaxis in hospital inpatients...
  16. ncbi request reprint ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidel
    Eugene Braunwald
    Circulation 106:1893-900. 2002
  17. ncbi request reprint Can beta-blocker use lower mortality and improve myocardial tissue recovery after acute myocardial infarction?
    David P Faxon
    Section of Cardiology at the University of Chicago, IL, USA
    Nat Clin Pract Cardiovasc Med 1:14-5. 2004
  18. ncbi request reprint ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guideli
    Eugene Braunwald
    J Am Coll Cardiol 40:1366-74. 2002
  19. ncbi request reprint ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Manage
    Robert O Bonow
    Circulation 114:e84-231. 2006
  20. ncbi request reprint Facilitated percutaneous coronary intervention
    William B Borden
    Section of Cardiology, Department of Medicine, University of Chicago, Chicago, Illinois, USA
    J Am Coll Cardiol 48:1120-8. 2006
    ....
  21. pmc The CHARISMA trial and the REACH registry outcomes
    David P Faxon
    J Natl Med Assoc 98:1713. 2006
  22. ncbi request reprint Development of systems of care for ST-elevation myocardial infarction patients: current state of ST-elevation myocardial infarction care
    David P Faxon
    Circulation 116:e29-32. 2007
  23. ncbi request reprint Development of systems of care for ST-elevation myocardial infarction patients: executive summary
    Alice K Jacobs
    Boston Medical Center, USA
    Circulation 116:217-30. 2007
  24. ncbi request reprint ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and
    Spencer B King
    Circulation 116:98-124. 2007
  25. ncbi request reprint ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and
    Spencer B King
    J Am Coll Cardiol 50:82-108. 2007
  26. ncbi request reprint Critical GI issues for the cardiologist: new insights and understanding. Introduction
    David P Faxon
    Section of Cardiology, University of Chicago, Chicago, Illinois, USA
    Rev Cardiovasc Med 6:S1-2. 2005
  27. ncbi request reprint Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices
    David P Faxon
    Section of Cardiology, University of Chicago, Chicago, Illinois, USA
    Rev Cardiovasc Med 6:S3-14. 2005
    ..The efficacy of antiplatelet therapy is thus well established in treating atherothrombosis, but aggressive therapy is associated with an increased bleeding risk. Newer agents may provide improved efficacy with a lower risk of bleeding...
  28. doi request reprint Utilization and outcomes of unprotected left main coronary artery stenting and coronary artery bypass graft surgery
    Chuntao Wu
    University at Albany, State University of New York, Albany, New York, USA
    Ann Thorac Surg 86:1153-9. 2008
    ..Limited contemporary information is available on outcomes for patients with unprotected left main coronary artery (LMCA) disease who are revascularized...
  29. doi request reprint Percutaneous coronary intervention for myocardial infarction with left ventricular dysfunction
    James D Flaherty
    Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA
    Am J Cardiol 102:38G-41G. 2008
    ....
  30. doi request reprint ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities
    Andrew E Epstein
    Heart Rhythm 5:e1-62. 2008
  31. ncbi request reprint Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial
    Shamir R Mehta
    Department of Medicine, McMaster University and Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada
    J Am Coll Cardiol 50:1742-51. 2007
    ..This study reports a prospectively planned analysis of patients with acute coronary syndrome who underwent early percutaneous coronary intervention (PCI) in the OASIS-5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial...
  32. pmc Antiplatelet therapy in populations at high risk of atherothrombosis
    David P Faxon
    Section of Cardiology, Department of Medicine, University of Chicago, 5841 S Maryland Ave, Room B 608, MC 6080, Chicago, IL 60637, USA
    J Natl Med Assoc 98:711-21. 2006
    ....
  33. ncbi request reprint Coronary interventions and their impact on post myocardial infarction survival
    David P Faxon
    Section of Cardiology, University of Chicago Hospitals, Chicago, IL 60637, USA
    Clin Cardiol 28:I38-44. 2005
    ..Myocardial injury following reperfusion after ischemia can limit the benefits of PCI and fibrinolysis; however, strategies for minimizing reperfusion injury have not yet shown clinical efficacy...
  34. ncbi request reprint ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guid
    Melvin D Cheitlin
    J Am Coll Cardiol 42:954-70. 2003
  35. ncbi request reprint Need for centers to care for patients with acute coronary syndromes
    Robert M Califf
    Division of Cardiology, Department of Medicine, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC 27715, USA
    Circulation 107:1467-70. 2003
  36. ncbi request reprint Current anticoagulation options in percutaneous intervention: designing patient-specific strategies
    Matthew H French
    Section of Cardiology, University of Chicago, Chicago, IL, USA
    Rev Cardiovasc Med 3:176-82. 2002
    ..However, the longer half-life and lack of monitoring of LMWH make its use more difficult. The direct thrombin inhibitors also have been shown to have advantages in the treatment of patients with heparin-induced thrombocytopenia...
  37. ncbi request reprint ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients
    Raymond J Gibbons
    Circulation 107:149-58. 2003
  38. ncbi request reprint ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines)
    Raymond J Gibbons
    J Am Coll Cardiol 40:1531-40. 2002
  39. ncbi request reprint ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to
    Gabriel Gregoratos
    Circulation 106:2145-61. 2002
  40. ncbi request reprint ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines)
    Raymond J Gibbons
    Circulation 106:1883-92. 2002
  41. ncbi request reprint Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry
    Alice K Jacobs
    Evans Memorial Department of Medicine, Boston University Medical Center, Boston, Massachusetts, USA
    J Am Coll Cardiol 39:1608-14. 2002
    ..The goal of this study was to determine whether women undergoing contemporary percutaneous coronary intervention (PCI) remain at increased risk in comparison with men and whether the outcomes in women have improved...
  42. ncbi request reprint ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guide
    Kim A Eagle
    Circulation 105:1257-67. 2002
  43. ncbi request reprint ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guideli
    Francis J Klocke
    J Am Coll Cardiol 42:1318-33. 2003
  44. ncbi request reprint From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I
    Morteza Naghavi
    The Center for Vulnerable Plaque Research, University of Texas Houston, The Texas Heart Institute, and President Bush Center for Cardiovascular Health, Memorial Hermann Hospital, Houston, USA
    Circulation 108:1664-72. 2003
    ..We encourage healthcare policy makers to promote translational research for screening and treatment of vulnerable patients...
  45. ncbi request reprint ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology
    Carina Blomstrom-Lundqvist
    Circulation 108:1871-909. 2003
  46. ncbi request reprint The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study
    David P Faxon
    Los Angeles County Medical Center and the University of Southern California School of Medicine, Los Angeles, California 60637, USA
    J Am Coll Cardiol 40:1199-204. 2002
    ..The purpose of this study was to determine whether Hu23F2G (LeukoArrest), an antibody to the CD11/CD18 integrin receptors, would reduce infarct size in patients undergoing primary angioplasty for an acute myocardial infarction...
  47. ncbi request reprint Plasma homocysteine levels and the left ventricular systolic function in coronary artery disease patients
    Syed W Bokhari
    University of Chicago Pritzker School of Medicine, Illinois 60637, USA
    Coron Artery Dis 16:153-61. 2005
    ..However, an association between hyperhomocysteinemia and the extent of coronary artery disease (CAD) remains controversial whereas its relationship with left ventricular systolic function has not been established...
  48. ncbi request reprint Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial
    Shamir R Mehta
    McMaster University and the Population Health Research Institute, Hamilton Health Sciences, General Division, 237 Barton St E, Hamilton, Ontario, Canada L6K 1B8
    Circulation 111:1390-7. 2005
    ..We performed a randomized trial to determine the safety and feasibility of fondaparinux in the percutaneous coronary intervention (PCI) setting...
  49. ncbi request reprint Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention
    Ruchira Glaser
    University of Pennsylvania, Philadelphia, PA 19104, USA
    Circulation 111:143-9. 2005
    ..Such lesions have been treated conservatively because of risk of restenosis but now are being considered for PCI to prevent plaque instability. However, the impact of incidental stenoses on future cardiac events remains unknown...
  50. ncbi request reprint ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Managem
    Elliott M Antman
    Circulation 110:e82-292. 2004
  51. ncbi request reprint Beta-blocker therapy and primary angioplasty: what is the controversy?
    David P Faxon
    J Am Coll Cardiol 43:1788-90. 2004
  52. ncbi request reprint Coronary artery compression caused by a large pseudoaneurysm complicating an acute myocardial infarction
    Neeraj Jolly
    Department of Medicine, Section of Cardiology, The University of Chicago, 5841 S Maryland Avenue, MC5076, Chicago, IL 60637, USA
    Echocardiography 21:85-6. 2004
  53. ncbi request reprint Percutaneous coronary intervention in women
    Elizabeth M Holper
    Section of Cardiology, University of Chicago, USA
    J Am Med Womens Assoc 58:264-71. 2003
    ..This review will examine the sex differences in demographics and outcomes of women undergoing PCI...
  54. ncbi request reprint ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology
    Carina Blomstrom-Lundqvist
    J Am Coll Cardiol 42:1493-531. 2003
  55. ncbi request reprint ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guide
    Kim A Eagle
    J Am Coll Cardiol 39:542-53. 2002